Erythropoietin overcomes imatinib-induced apoptosis and induces erythroid differentiation in TF-1/bcr-abl cells

Stem Cells

Volumn 22, Issue 4, 2004, Pages 609-616

  Uchida, Mie ^a   Watanabe, Tomoko ^a   Kunitama, Masae ^a   Mori, Masaki ^a   Kikuchi, Satoru ^a   Yoshida, Kozue ^a   Kirito, Keita ^a   Nagai, Tadashi ^a   Ozawa, Keiya ^a   Komatsu, Norio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

CML; Erythroid differentiation; Erythropoietin; FKHRL1; Imatinib

Indexed keywords

BCR ABL PROTEIN; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMATINIB; PROTEIN BCL XL; PROTEIN P27; STAT PROTEIN; TRANSCRIPTION FACTOR FKHR;

APOPTOSIS; ARTICLE; BLAST CELL CRISIS; CANCER CELL CULTURE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN TF 1; CHRONIC MYELOID LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG RESPONSE; ERYTHROID CELL; ERYTHROPOIESIS; FUSION GENE; GENE CONTROL; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; PROTEIN PHOSPHORYLATION; UPREGULATION;

EID: 3543043743     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.22-4-609     Document Type: Article

References (32)

1. McLaughlin J, Chianese E, Witte ON. In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci U S A 1987;84:6558-6562.
2. Daley GQ, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci U S A 1988;85:9312-9316.
3. Kantarjian H, Sawyers C, Hochhaus A et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002;346:645-652.
4. O'Brien SG, Guilhot F, Larson RA et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003;348:994-1004.
5. Talpaz M, Silver RT, Druker BJ et al. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood 2002;99:1928-1937.
6. Sawyers CL, Hochhaus A, Feldman E et al. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood 2002;99:3530-3539.
7. Druker BJ, Sawyers CL, Kantarjian H et al. Activity of a specific inhibitor of the BCRABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001;344:1038-1042.
8. Druker BJ, Tamura S, Buchdunger E et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996;2:561-566.
9. Deininger MW, Goldman JM, Lydon N et al. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells. Blood 1997;90:3691-3698.
10. Kitamura T, Tange T, Terasawa T et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989;140:323-334.
11. Nakajima A, Tauchi T, Ohyashiki K. ABL-specific tyrosine kinase inhibitor, STI571 in vitro, affects Ph-positive acute lymphoblastic leukemia and chronic myelogenous leukemia in blastic crisis. Leukemia 2001;15:989-990.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
13. Dumon S, Santos SC, Debierre-Grockiego F et al. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene 1999;18:4191-4199.
14. Horita M, Andreu EJ, Benito A et al. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J Exp Med 2000;191:977-984.
15. Komatsu N, Watanabe T, Uchida M et al. A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells. J Biol Chem 2003;278:6411-6419.
16. Wakao H, Harada N, Kitamura T et al. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J 1995;14:2527-2535.
17. Gouilleux F, Pallard C, Dusanter-Fourt I et al. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGFStat5 DNA binding activity. EMBO J 1995;14:2005-2013.
18. -/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 1999; 98:181-191.
19. Packham G, White EL, Eischen CM et al. Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev 1998;12:2475-2487.
20. Silva M, Benito A, Sanz C et al. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 1999;274:22165-22169.
21. Anderson MJ, Viars CS, Czekay Set al. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 1998;47:187-199.
22. Kaufmann E, Knochel W. Five years on the wings of fork head. Mech Dev 1996;57:3-20.
23. Lin K, Dorman JB, Rodan A et al. daf-16: an HNF-3/forkhead family member that can function to double the lifespan of Caenorhabditis elegans. Science 1997;278:1319-1322.
24. Ogg S, Paradis S, Gottlieb S et al. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 1997;389:9194-999.
25. Brunet A, Bonni A, Zigmond MJ et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96:857-868.
26. Kashii Y, Uchida M, Kirito K et al. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 2000;96:941-949.
27. Tanaka M, Kirito K, Kashii Y et al. Forkhead family transcription factor FKHRL1 is expressed in human megakaryocytes: regulation of cell cycling as a downstream molecule of thrombopoietin signaling. J Biol Chem 2001;276:15082-15089.
28. Dijkers PF, Medema RH, Pals C et al. Forkhead transcription factor FKHRL-1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol 2000;20:9138-9148.
29. Dijkers PF, Medema RH, Lammers JW et al. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 2000;10:1201-1204.
30. Fang G, Kim CN, Perkins CL et al. CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs. Blood 2000;96:2246-2253.
31. Bartolovic K, Balabanov S, Hartmann U et al. Inhibitory effect of imatinib on normal progenitor cells in vitro. Blood 2004;103:523-529.
32. Heim D, Ebnother M, Meyer-Monard S et al. G-CSF for imatinib-induced neutropenia. Leukemia 2003;17:805-807.